An egg cell is the largest cell in the human body. It contains a large volume of cytoplasm and intracellular fluid, making it extremely difficult to freeze using standard slow-freezing methods without the risk of ice microcrystals forming, which can rupture the delicate cell membranes. To ensure that damage to the cell’s ultrastructures and the spindle apparatus is avoided, the vitrification method is used for long-term storage—that is, instantaneous, ultra-rapid freezing in liquid nitrogen using special concentrated cryoprotectants. Cryoprotectants rapidly displace the water inside the cell, transforming its contents into an amorphous, glass-like state without destructive crystallization.
The chances of successful fertilization, embryonic development, and the birth of a healthy child when using vitrified oocytes are determined by two key biological factors:
- The woman’s age at the time of egg retrieval and cryopreservation.
- The total number of morphologically mature eggs retrieved and preserved.
The required number of MII-stage oocytes at different ages
To achieve a reliable clinical outcome depending on the patient’s age, the following practical guidelines apply in modern reproductive medicine:
- A 35-year-old woman typically needs to undergo 1–2 cycles of ovarian stimulation to preserve at least 16 mature oocytes at the second stage of meiosis (MII). This ensures a consistent 80–85% probability of giving birth to one healthy child in the future.
- Women under 38 years of age need to cryopreserve 18 to 20 MII oocytes to achieve a cumulative 70–80% chance of giving birth to one healthy baby.
- Women aged 38–40 need to freeze 25 to 30 MII oocytes to achieve a 65–75% probability of giving birth to one child.
There is a precise predictive model for the probability of having children based on a woman’s age at the time of egg retrieval. It clearly illustrates a key biological difference: if three women aged 34, 37, and 42 cryopreserve exactly the same number of cells (20 mature oocytes each), the chance of giving birth to one live child will be 90%, 75%, and 37%, respectively. This marked difference is due to the natural increase in the rate of genetic damage in gametes as the body matures biologically. Oocytes are formed during the woman’s prenatal development and, throughout her life, are subject to the accumulation of oxidative stress and metabolic wear and tear.
Probability of Having a Child Based on Age and Number of Eggs
Precise estimates of successful births depend directly on the patient’s individual reproductive age at the time of ovarian puncture and the total volume of collected biomaterial. The statistics for the chances of a successful birth are distributed as follows:
- For a 30-year-old: preserving 5 oocytes yields a 64% probability; 10 oocytes increase the chance to 87%; 15 oocytes provide a 95% probability; 20 oocytes yield a 98% probability; and with 25 oocytes, the probability reaches an impressive 99%.
- For women aged 32: freezing 5 oocytes yields a 55% chance of success; freezing 10 oocytes increases this to 80%; 15 oocytes yield a 91% success rate; 20 oocytes guarantee a 96% success rate; and 25 oocytes yield a 98% overall success rate.
- For a 34-year-old: 5 preserved oocytes provide a 47% probability; 10 oocytes yield 72%; with 15 oocytes, the rate is 85%; with 20 oocytes, it reaches 92%; and with a reserve of 25 oocytes, the success rate is 96%.
- For a 36-year-old: with 5 oocytes, the probability is 40%; freezing 10 oocytes yields a 64% probability; 15 oocytes yield 78%; 20 oocytes increase the overall probability to 87%; and 25 oocytes yield 92%.
- For a woman aged 38: freezing 5 oocytes results in a 26% success rate; 10 oocytes yield 44%; 15 oocytes yield 59%; a supply of 20 oocytes guarantees 69%; and 25 oocytes yield a 77% probability.
- For women aged 40: having 5 oocytes yields only a 17% chance, 10 oocytes yield 31%, 15 oocytes raise the rate to 42%, 20 oocytes yield 52%, and 25 oocytes yield a 60% chance.
- For a woman aged 42: having 5 oocytes yields only a 10% chance, 10 oocytes yield 19%, 15 oocytes guarantee 28%, 20 oocytes yield a 35% probability, and 25 oocytes yield a 42% probability.
These figures clearly demonstrate that at a young age, even a relatively small supply of biomaterial yields a high success rate. For example, for a 30-year-old woman, having 10 oocytes already ensures an 87% success rate, whereas at age 40, even 20 preserved oocytes yield only a 52% probability due to age-related declines in oocyte viability.
Advantages of Cryopreservation Before Age 35
Reproductive outcomes and success rates of assisted reproduction programs are significantly higher in women aged 35 and younger at the time of oocyte cryopreservation compared to patients in the older age group. At a young age, the cell membrane remains elastic, and cytoplasmic organelles, including mitochondria, produce sufficient energy for proper cell division after fertilization.
Women over the age of 35 often require more than one consecutive cycle of ovarian stimulation to accumulate a sufficient number of eggs and achieve a high probability of a successful pregnancy. Clinical data show that the overall success rate—including developing pregnancies and the birth of live, full-term infants—drops significantly if a woman is over 40 at the time of vitrification.
From a financial, organizational, and purely medical standpoint, the FERTIFREEZE Fertility Preservation Program is most cost-effective and successful for women under the age of 35. During this optimal period, ovarian reserve remains at a consistently high level; therefore, a single standard stimulation protocol is usually sufficient to retrieve the target number of high-quality oocytes for vitrification with maximum reproductive potential. This minimizes the medication burden on the body and significantly reduces the financial costs of repeat stimulation cycles.
The likelihood that frozen eggs will actually be needed increases significantly as a woman ages, and after age 35, it exceeds 61%. The overwhelming majority of patients surveyed confirm that they have absolutely no regrets about participating in the deferred motherhood program, viewing their preserved young eggs as reliable biological insurance against the potential risk of infertility in the future.
A striking example of this informed approach among global celebrities is actress Priyanka Chopra. She has publicly shared that she decided to undergo egg cryopreservation when she was just over 30 years old, following the recommendation of her mother, a practicing obstetrician-gynecologist. The actress admitted that this step gave her an incredible sense of inner freedom and relieved the oppressive psychological pressure of her biological clock, allowing her to calmly build her career and wait to meet her future spouse without fear of missing the opportunity to become a mother.
The Effect of Storage Duration on the Health of the Future Child
The length of time oocytes are stored in a specialized cryobank has absolutely no negative effect on the risk of aneuploidy—that is, abnormalities in the normal chromosome set of the future embryo. Prolonged exposure to extreme cold does not alter gene expression profiles in thawed cells and does not disrupt metabolic processes after their activation. Long-term international observations and clinical studies have also failed to reveal an increased incidence of obstetric or perinatal complications in pregnancies achieved using vitrified oocytes compared to standard conception protocols. Embryonic development proceeds in a completely physiological manner, and the health indicators of the children born fully correspond to general population norms.
ART Programs for Declining Fertility
When a woman’s natural egg supply is depleted or their quality—due to age or underlying gynecological conditions—prevents the formation of a viable embryo, modern reproductive medicine offers several effective protocols to overcome infertility.
The primary clinical approach is IVF (in vitro fertilization)—the fertilization of a woman’s own eggs with her spouse’s or partner’s sperm under laboratory conditions in an embryology suite. The resulting embryos are cultured in high-tech incubators until the blastocyst stage on the fifth or sixth day, after which one promising embryo is transferred to the uterine cavity, and the remaining high-grade cells are safely vitrified. This method is most effective as long as the ovarian follicular reserve is capable of producing a sufficient number of mature and genetically sound eggs. However, after age 40–42, the success rate of the standard protocol using the woman’s own oocytes drops sharply due to a high rate of associated chromosomal abnormalities.
If the patient’s own oocyte reserve is critically depleted, if she has entered premature or natural menopause, or if repeated standard attempts have been unsuccessful, patients are recommended to undergo IVF with egg donation. In this case, mature oocytes from young, physically and mentally healthy female donors under the age of 32 who have undergone comprehensive genetic, medical, and infectious disease screening are used for fertilization. The retrieved donor oocytes are fertilized with the partner’s sperm. Thanks to the excellent biological quality of the donor material, the probability of achieving a clinical pregnancy and a successful delivery in such protocols consistently exceeds 60–65% from the very first attempt, regardless of the prospective mother’s actual age.
In cases where severe combined forms of male and female infertility have been diagnosed, or where both partners are completely lacking in gametes, IVF with dual donation becomes the only option. This option is also relevant for single women with significantly depleted ovarian reserve or a high, confirmed risk of transmitting severe hereditary disorders through both parental lines. As part of a comprehensive program, embryologists fertilize a donor egg with sperm from a verified donor in the database; the resulting high-quality embryo is then transferred to the patient’s prepared uterus for a comfortable pregnancy and a natural, uncomplicated delivery.
Frequently Asked Questions
At what age is it best to freeze eggs?
The most favorable period for cryopreservation is up to age 35, primarily between the ages of 28 and 34. In this age range, the ovarian reserve is sufficiently large, spontaneous chromosomal abnormalities in oocytes occur much less frequently, and a single egg retrieval is usually sufficient to obtain an adequate number of eggs.
How long can eggs remain frozen?
Biological material is stored in airtight cryotubes inside Dewar flasks filled with liquid nitrogen at a constant temperature of minus 196 degrees Celsius. At such a low temperature, absolutely all biochemical and metabolic processes within the cell come to a complete halt, allowing oocytes to retain their original biological quality for years and decades without any time limitations.
Does the procedure provide an absolute guarantee of having a child?
In evidence-based reproductive medicine, it is impossible to provide a 100% guarantee, since successful embryo implantation and the course of the entire pregnancy are influenced by the prospective mother’s overall physical health, the condition of the endometrium, and other contributing factors. Nevertheless, cryopreservation of 15 to 20 oocytes before the age of 35 yields an estimated success rate of up to 95–98%, which is the highest achievable rate in modern medicine.
Does egg retrieval deplete a woman’s ovarian reserve?
No, the retrieval procedure and hormonal stimulation do not in any way cause the natural follicular reserve of eggs to deplete prematurely. In every natural menstrual cycle, a woman’s body activates a certain cohort of follicles, but only one dominant follicle reaches the ovulation stage, while the remaining follicles undergo atresia and are irreversibly lost. Medical stimulation merely helps those cells in this cohort—which the body would inevitably have lost that month—to mature.
What happens to the biological material if pregnancy occurs naturally
If a woman successfully conceives and gives birth to a healthy child naturally, the previously preserved young oocytes remain in the clinic’s cryobank. They can easily be used later to plan for a second or third child at a more mature age, donated to a donor program to help other families at the woman’s discretion, or disposed of upon submission of an official written request.